CannMed Coffee Talk

In this episode, we talk with Dr. Van Butsic, the Co-director of the Berkeley Cannabis Research Center and Cooperative Extension Specialist at UC Berkeley. The Cannabis Research Center uses an interdisciplinary approach to address questions at the intersection of cannabis policy, the environment, and cannabis-producing communities. At CannMed 2021, Van will participate in a panel discussion about...

Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of research into the endocannabinoid system that followed, Professor Mechoulam is often called the “Godfather of cannabis research”.  Since his research began in the 1960s, Professor Mechoulam has received numerous academic award...

This episode’s guest is Hope Jones. She is the CEO of Superior Phenos, LLC, a hemp young plant production company in Arizona and CEO of Emergent Cannabis Sciences, an international cannabis and micropropagation consulting company with clients in Colombia, Australia, Germany and Canada. Dr. Jones has deep expertise in both hemp and cannabis often serving as an expert consultant on forming policy at...

Our guest in this episode is Dr. Mauro Maccarrone. Mauro is a pioneer in endocannabinoid research. In 1997, his team identified the receptor targets for the first two endocannabinoids that were discovered by Professor Raphael Mechoulam earlier in the decade: anandamide and 2-AG. Since then, the endocannabinoid system has been the focus of his research.  At CannMed 2021 he will present &#...

Our guest this week is Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber has spent decades investigating how both recreational and medical cannabis use affects the brain. In 2014, Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery...

On this episode, we talked with tissue culture expert, Mark Jordan. Mark is currently the Chief Executive Officer at Minibis headquartered in Longmont, CO, where he started a tissue culture lab dedicated to Cannabis research and development. His previous positions include work at Colorado Seed Incorporated, Eurofins Biodiagnostics, and the Denver Botanic Gardens. While at the Denver Botanic Garden...

On this episode we welcome Dr. Marion McNabb, President of the Cannabis Center of Excellence INC and CEO of Cannabis Community Care and Research Network (C3RN). Marion is a Public Health Doctor by training that has nearly 20 years of global and domestic public health experience. Her team recently completed a veterans’ health and medical cannabis research study with the goal of gathering informatio...

On this episode we welcome Dr. Kevin Spelman from the National University of Natural Medicine. Kevin has a wealth of knowledge when it comes to medicinal plant, nutraceutical, and cannabinoid research and has authored 29 peer-reviewed publications on medicinal plants. Over the last 30 years, he has coordinated new product development, formulated product lines, advised on analytical and QC guidelin...

This episode’s guest is Jordan Zager, co-founder and CEO of Dewey Scientific. Jordan is an expert in cannabis genetics and natural product biosynthesis, having authored multiple research papers in the fields of trichome development and metabolism, mathematical modeling of biochemical pathways, and functional genomics.  Jordan’s CannMed 2021 presentation is titled “ Gene Networks Underly...

We are excited to announce CannMed 2021’s Keynote Presenter in the Safety Focus Area is Grace Bandong, Scientific Strategy Leader Contaminants for Eurofins Food Integrity and Innovations. The title of Ms. Bandong’s presentation is “ Risk Based Hazards Analysis: A Tool for Building A Comprehensive Analytical Testing Program ,” in which she will explore the vulnerability of products/ingredients to c...

This episode’s guest is plant pathology expert Zamir Punja, PhD of Simon Fraser University’s Department of Biological Sciences. Zamir’s research investigates the causes and management of plant diseases on cannabis, including fusarium, penicillium, powdery mildew, botrytis, as well as new and emerging plant pathogens. His CannMed 2018 presentation featured several amazing images Zam...

This episode’s guest is Michael Levinsohn. Michael is a criminal and civil defense attorney with 20 years of experience representing people in all areas of the cannabis business. On the podcast, we discuss the legal aspects of practicing cannabis medicine, including: The need for more clinicians who are educated in cannabis medicine to help guide patients and defend them should they run into legal...

On this episode, we talk with Cindy Orser, PhD, the Chief Scientific Officer at CLIP LABS. Dr. Orser has more than 25 years of experience innovating technologies related to cannabis, human diagnostics, and even detecting biothreat agents. We spent most of the conversation talking about the panel Cindy will moderate at CannMed 2021, titled “The Hidden Cost of Cannabis: Environmental Impact”....

Keith Allen is the Director of Bioinformatics at Front Range Biosciences. Keith is tasked with exploring the cannabis genome to find genetic markers that can be selected in breeding projects. His current focus is on cannabinoid and terpene production, but as we discuss in our conversation, there are a number of different traits cannabis and hemp breeders will want to select for in the future, incl...

On this episode, we talk with CannMed 2020 presenter Eloise Theisen of Radicle Health. Eloise is a board-certified Adult Geriatric Nurse Practitioner with over 20 years experience in nursing. She started her own cannabis practice about 6 years ago and she has treated over 6000 patients using cannabis. There are very few healthcare providers nationally with the same level of expertise and experienc...

On the latest episode of CannMed Coffee Talk, we welcome Brianna Cassidy, Chief Science Officer of CDX Analytics. Brianna and the team at CDX perform safety testing on all types of cannabis samples, including potency, pesticides, heavy metals, residual solvents, and microbial contamination. As you will hear in the podcast, Brianna takes a creative and analytical approach to solving problems that c...

We are excited to announce CannMed 2020’s Keynote Presenter in the Cultivation Focus Area, and our guest on the latest Coffee Talk Podcast, is Seth Crawford, PhD. Dr. Crawford is the owner and co-founder of Oregon CBD , along with his brother, Eric. Together (and with the help of some 41 scientists, geneticists and breeders) they specialize in turning out new, exciting and unique strains of indust...

In this episode we get the chance to talk with our first representative from the Safety Focus Area. Ini Afia is the Scientific Director at CannaSafe Labs, one of the largest cannabis testing labs in California. If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. The cannabis testing labs are sort of like unsung heroes in the cannabis industry...

We are excited to announce Bonni S. Goldstein, MD as the CannMed 2020’s Keynote Presenter in the Medicine Focus Area. The title of Dr. Goldstein’s presentation is “Cannabis Medicine for Children.” She will be sharing her latest clinical findings, including promising results from her clinical practice focusing on the use of phytocannabinoid medicines to treat serious pediatric medical condition, in...

In this episode of CannMed Coffee Talk we talk with Martin A. Lee, the co-founder and director of  Project CBD . In addition to creating content for the Project CBD website and speaking at conferences around the globe, Martin has authored several books, including Smoke Signals: A Social History of Marijuana–Medical, Recreational and Scientific . In fact, we have a copy in our Medicinal G...

We are excited to announce CannMed 2020’s Keynote Presenter in the Science Focus Area is Dr. Ethan Russo. The title of Dr. Russo’s presentation is “Cannabis and Psychiatry: The Final Frontier”, and it will explore basic science and clinical trial data to assess the role of cannabis psychopharmacology with respect to issues of impairment, depression, insomnia, PTSD, schizophrenia, anxiety and addic...

We have a great episode for you today featuring Medicinal Genomics Chief Scientific Officer Kevin McKernan. Kevin is a legend in the genomic sequencing space going back to his days working on the human genome project. He has applied his experience and knowledge to trying to better understand the cannabis genome, which as he mentions in the episode is one of the hardest genomes to figure out. So mu...

Medicinal Genomics  invites you to listen to our new CannMed Coffee Talk Podcast. Each episode we talk with the leading minds in cannabis science, medicine, cultivation, and safety testing, discussing topics from the bench to the bedside. Don’t miss this opportunity to get a sneak-peek into the 4 FOCUS AREAS that will be covered at  CannMed 2020  in Pasadena, CA on ...